Document is current
Any future updates will be listed below
-
Authors
Wu, Chia-Chin http://orcid.org/0000-0002-5208-6016
Beird, Hannah C. http://orcid.org/0000-0002-5078-534X
Lamhamedi-Cherradi, Salah-Eddine http://orcid.org/0000-0002-8324-4769
Soeung, Melinda
Ingram, Davis
Truong, Danh D. http://orcid.org/0000-0003-3200-1297
Porter, Robert W. http://orcid.org/0000-0001-8126-3045
Krishnan, Sandhya
Little, Latasha
Gumbs, Curtis
Zhang, Jianhua
Titus, Mark
Genovese, Giannicola
Ludwig, Joseph A. http://orcid.org/0000-0001-6631-8554
Lazar, Alexander J. http://orcid.org/0000-0002-6395-4499
Hayes-Jordan, Andrea
Futreal, P. Andrew http://orcid.org/0000-0001-8663-2671
-
Funding
Funding for this research was provided by:
the Welch Foundation’s Robert A. Welch Distinguished University Chair Award (G-0040).
Neubauer Family Foundation: a charitable organization
Cory Monzingo Foundation: a charitable organization to support the research for treatments and a cure for DSRCT.
- License Information
-
More Information
Article History
Received: 18 March 2021
Accepted: 3 February 2022
First Online: 4 April 2022
Ethics approval and consent to participate
: The collection of DSRCT tumor patients was approved by the Institutional Review Board of MDACC under the LAB08-0151 and LAB06-0536 protocols, and conducted in compliance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all patients, but it was not required for these multi-site genomic analyses, and all the patient records were de-identified before analysis.
: The authors declare no competing interests.
